Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
New Zealand Invstb Mkt Idx MSCI Ishares | ENZL | 5. nov 2024 | 47.88 | +2.02 |
NewAmsterdam Pharma N.V | NAMS | 5. nov 2024 | 19.15 | +6.21 |
Newbury Street Acquisition | NBST | 5. nov 2024 | 10.93 | 0.00 |
Newbury Street Acquisition Unit | NBSTU | 5. nov 2024 | 10.87 | 0.00 |
Newegg Commerce | NEGG | 5. nov 2024 | 0.66 | +4.66 |
Newell Brands | NWL | 5. nov 2024 | 8.85 | +1.26 |
NewGenIvf Group | NIVF | 5. nov 2024 | 0.72 | +6.26 |
NewJersey Resources | NJR | 5. nov 2024 | 45.69 | +1.15 |
Newmark Group A | NMRK | 5. nov 2024 | 14.90 | +1.71 |
NewMarket | NEU | 5. nov 2024 | 534.42 | +1.82 |
Newmont | NEM | 5. nov 2024 | 46.00 | +0.52 |
Newpark Resources | NR | 5. nov 2024 | 6.92 | +5.33 |
News A | NWSA | 5. nov 2024 | 27.85 | +1.57 |
News B | NWS | 5. nov 2024 | 29.79 | +1.71 |
NewtekOne | NEWT | 5. nov 2024 | 13.20 | +2.25 |
Nexa Resources | NEXA | 5. nov 2024 | 7.90 | +2.73 |
Nexalin Technology | NXL | 5. nov 2024 | 2.85 | +5.17 |
NexGel | NXGL | 5. nov 2024 | 2.81 | -4.58 |
NexGen | NXE | 5. nov 2024 | 7.11 | -0.70 |
NexImmune | NEXI | 5. nov 2024 | 2.31 | 0.00 |
NexPoint Diversified Real Estate Trust Pref | NXDT-A | 5. nov 2024 | 15.90 | +1.08 |
Nexpoint Diversified REIT | NXDT | 5. nov 2024 | 5.82 | +3.01 |
Nexpoint Real Estate Finance | NREF | 5. nov 2024 | 14.86 | -2.17 |
NexPoint Real Estate Finance A | NREF-A | 5. nov 2024 | 24.15 | +0.21 |
Nexpoint Residential Trust | NXRT | 5. nov 2024 | 42.32 | +2.74 |
Nexstar Media Group A | NXST | 5. nov 2024 | 172.87 | -0.41 |
Next Technology | NXTT | 5. nov 2024 | 1.00 | +0.01 |
NextCure | NXTC | 5. nov 2024 | 1.31 | 0.00 |
NextDecade | NEXT | 5. nov 2024 | 5.95 | +8.58 |
Nextdoor | KIND | 5. nov 2024 | 2.50 | +3.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.